Table 1.
Characteristics of participants
22q11DS (n = 16) | Controls (n = 12) | p | |
---|---|---|---|
Age (SD) | 28.2 (6) | 29 (9.6) | 0.79 |
Gender (M/F) | 8/8 | 8/4 | 0.46 |
IQ (SD) | 77 (10) | 110 (10) | <0.001 |
Psychosis (Y/N) | 5/11 | ||
COMT genotype (Met/Val) | 6/10 | ||
PANSS total | 45.5 | ||
PANSS positive | 8.4 | ||
PANSS negative | 13.9 | ||
Medication (n) | Quetiapine (3) | ||
Risperidone (1) | |||
Lithiumcarbonate (1) | |||
Paroxetine (1) | |||
Methylphenidate (1) | |||
Venlafaxine (1) | |||
Clozapine (1) | |||
Lamotrigine (1) |